Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial

Journal of Acquired Immune Deficiency Syndromes

Volumn 65, Issue 3, 2014, Pages 366-374

  Fowler, Mary Glenn ^a   Coovadia, Hoosen ^b   Herron, Casey M ^c   Maldonado, Yvonne ^d   Chipato, Tsungai ^e   Moodley, Dhayendre ^f   Musoke, Philippa ^g   Aizire, Jim ^g   Manji, Karim ^h   Stranix Chibanda, Lynda ^e   Fawzi, Wafaie ⁱ   Chetty, Vani ^f   Msweli, Lindiwe ^f   Kisenge, Rodrick ^h   Brown, Elizabeth ^c   Mwatha, Anthony ^c   Eshleman, Susan H ^a   Richardson, Paul ^a   Allen, Melissa ^g   George, Kathleen ⁱ   Andrew, Philip ^j   Zwerski, Sheryl ^k   Mofenson, Lynne M ^l   Jackson, J Brooks ^a   more..

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c USA   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^f UNIVERSITY OF KWAZULU NATAL   (South Africa)

^g MAKERERE UNIVERSITY   (Uganda)

^h MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

ⁱ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^j FAMILY HEALTH INTERNATIONAL   (United States)

^k NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^l EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

more..

Author keywords

infant HIV prophylaxis; nevirapine; PMTCT

Indexed keywords

ADOLESCENT; ADULT; AFRICA; ANTI-HIV AGENTS; BREAST FEEDING; CHEMOPREVENTION; DOUBLE-BLIND METHOD; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; NEVIRAPINE; PLACEBOS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84894411109     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000052     Document Type: Conference Paper

References (23)

1. UNAIDS. UNAIDS Report on the Global AIDS Epidemic j 2012. Available at: Http://www.unaids.org/en/media/unaids/contentassets/documents/ epidemiology/2012/gr2012/20121120-UNAIDS-Global-Report-2012- en.pdf. Accessed September 12, 2013
2. Bedri A, Gudetta B, Isehak A, et al. Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: An analysis of three randomised controlled trials. Lancet. 2008;372:300-313
3. Kumwenda NI, Hoover DR, Mofenson LM, et al. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med. 2008;359:119-129
4. Chasela CS, Hudgens MG, Jamieson DJ, et al. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med. 2010;362: 2271-2281
5. Shapiro RL, Hughes MD, Ogwu A, et al. Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med. 2010;362: 2282-2294
6. de Vincenzi I. Triple antiretroviral compared with zidovudine and singledose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-To-child transmission of HIV-1 (Kesho Bora study): A randomised controlled trial. Lancet Infect Dxis. 2011;11:171-180
7. WHO. Guidelines on HIV and Infant Feeding 2010. PRinciples and Recommendations for Infant Feeding in the Context of HIV and a Summary of Evidence. Available at: Http://www.who.int/maternal-child- adolescent/documents/ 9789241599535/en/. Accessed September 12, 2013
8. WHO. Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants. REcommendations for a Public Health Approach 2010 Version. Available at: Http://whqlibdoc.who.int/publications/2010/ 9789241599818-eng. pdf. Accessed September 12, 2013
9. WHO. Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants Executive Summary April 2012. Available at: Http://www.who.int/hiv/PMTCT-update.pdf. Accessed September 12, 2013
10. World Health Organization HIV/AIDS Programme. Consolidated Guidelines on the Use of Antiretroviral Drug for Treatment and Preventing HIV Infection: Recommendations for a Public Health Approach. Geneva, Switzerland: 2013. Printed Kuala Lumpur Malaysia. Available at: Http:// www.who.int/hiv/pub/guidelines/ arv2013/intro/executivesummary/en/index. html. Accessed September 12, 2013
11. Coovadia HM, Brown ER, Fowler MG, et al. Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): A randomised, double-blind, placebo-controlled trial. Lancet. 2012;379:221-228
12. Division of AIDS (DAIDS) Table for Grading Severity the Severity of Adult and Pediatric Adverse Events. Version 1.0; December, 2004; Clarification August 2009. Available at: Http://rsc.tech-res.com/Document/ safetyandpharmacovigilance/Table-for-Grading-Severity-of-Adult- Pediatric-Adverse-Events.pdf. Accessed September 12, 2013
13. Taha TE, Kumwenda J, Cole SR, et al. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy. J Infect Dis. 2009;200:1490-1497
14. Jamieson DJ, Chasela CS, Hudgens MG, et al. Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial. Lancet. 2012;379:2449-2458
15. Coutsoudis A, Dabis F, Fawzi W, et al. Late postnatal transmission of HIV-1 in breast-fed children: An individual patient data meta-Analysis. J Infect Dis. 2004;189:2154-2166
16. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493-505
17. Nachega J, Uthman O, Mills E, et al. Adherence to ART during and after Prengancy in Low, Middle, and High-Income Countries: A Systematic Review and Meta-Analyses. 19th Conference on Retroviruses and Opportunistic Infections (CROI). Alexandria, VA: CROI LLC; 2012:468
18. Clouse K, Maskew M, Bassett J, et al. Delayed Diagnosis of HIV and High Rates of Lost to Follow-up Among Pregnant Women Attending Antenatal Services at a Primary Health Clinic: Johannesburg, South Africa 19th Conference on Retroviruses and Opportunistic Infections (CROI). Seattle, WA: Abstract 1004, Program Abstracts; 2012:467
19. Rawizza H, Meloni S, Oyebode T, et al. Evaluation of Loss to Follow up Within the PMTCT Care Cascade in a Large ART Program: Nigeria. 19th Conference on Retroviruses and Opportunistic Infections (CROI). Alexandria, VA: CROI LLC; 2012:474
20. Kreitchmann R, Harris R, Kakehasi F, et al. ARV Adherence during Pregnancy and Post Partum: Latin America. 19th Conference on Retroviruses and Opportunistic Infections (CROI). Alexandria, VA: CROI LLC; 2012:474
21. Zeh C, Weidle PJ, Nafisa L, et al. HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-Arm trial of triple-Antiretroviral prophylaxis for prevention of mother-To-child transmission: A secondary analysis. PLoS med. 2011;8:e1000430
22. Fogel J, Li Q, Taha TE, et al. Initiation of antiretroviral treatment in women after delivery can induce multiclass drug resistance in breastfeeding HIV-infected infants. Clin Infect Dis. 2011;52:1069-1076
23. Kuhn L, Aldrovandi GM, Sinkala M, et al. Potential impact of new WHO criteria for antiretroviral treatment for prevention of mother-To-child HIV transmission. AIDS. 2010;24:1374-1377